AFRM vs ALZN · P/E 590, rev $4.26B vs $2.4M cap
Affirm Holdings Inc (AFRM) versus Alzamend Neuro Inc (ALZN) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Alzamend Neuro Inc (ALZN) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2026-06-30 was $4.26B. Net income was $1.93B. Revenue was up 32.2% from 2025-06-30 to 2026-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
ALZN does not have a complete income-statement cache yet.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. ALZN currently screens at market cap $2.4M.
Not investment advice. Open the AFRM and ALZN stock pages for the full models.
Not investment advice.